Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $23.43 Million |
|---|---|
| Enterprise Value | $30.32 Million |
| Earnings per Share | $-0.04 |
| Beta | -0.13 |
| Outstanding Shares | 320,983,589 |
| P/E Ratio | -1.55 |
|---|---|
| PEG | 2.59 |
| Price to Sales | - |
| Price to Book Ratio | -0.07 |
| Enterprise Value to Revenue | 7.45 |
| Enterprise Value to EBIT | -1.98 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | -1.6 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.04%0% |
|---|---|
| Total Invested | $9,604▼ 28.19% |
| Investors Holding | 10% |
BioLargo, Inc. pioneers the invention, development, and commercialization of sophisticated platform technologies. The company is dedicated to tackling critical environmental challenges, such as per- and polyfluoroalkyl substances (PFAS) ...